iqvia semaglutide tirzepatide prescriptions us q3 2024 Weight Loss Dynamics and Health Burden Changes with versus Global Medicines Outlook 2024-2028 |

The CMAJ guidance A guidance article published in the Canadian Medical Association Journal (CMAJ) on glucagon-like peptide-1 receptor agonists during pregnancy and lactation concluded that while the safety data is limited, the pharmacological properties of GLP-1 agonists (large molecular weight, poor oral bioavailability) suggest low theoretical risk during breastfeeding

doi: 10.1016/S0140-6736(09)61375-1 90 LeanMEJCarraroRFinerNHartvigHLindegaardMLRssnerSet al

Eighteen months ago, she turned to tirzepatide, the active ingredient in GLP-1s like Mounjaro and Zepbound

Consult Your Doctor : Always talk to your healthcare provider about any side effects you experience